Leucemia mieloide acuta e gilteritinib

Prof. Felicetto Ferrara
Leucemia mieloide acuta e gilteritinib
Wang ES et al. Phase 3 Trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy. Blood August 2.
Daver N et al. Venetoclax plus gilteritinib for FLT3-mutated relapsed/refractory acute myeloid leukemia. J Clin Oncil Sept 5, 2022.